These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28397153)

  • 1. MELDNa score is associated with psychopathology and reduced quality of life in cirrhotic patients with a liver transplant perspective.
    Cavaggioni G; Poli E; Ferri F; Parlati L; Monaco V; Melcore C; Lattanzi B; Merli M; Mennini G; Melandro F; Rossi M; Ginanni Corradini S
    Metab Brain Dis; 2017 Jun; 32(3):923-933. PubMed ID: 28397153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Acharya C; White MB; Fagan A; Sterling RK; Stravitz RT; Puri P; Fuchs M; Luketic V; Sanyal AJ; Wade JB; Gilles H; Heuman DM; Tinsley F; Matherly S; Lee H; Siddiqui MS; Thacker LR; Bajaj JS
    Dig Dis Sci; 2021 Apr; 66(4):1360-1366. PubMed ID: 32323075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
    Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.
    Palmieri VO; Santovito D; Margari F; Lozupone M; Minerva F; Di Gennaro C; Todarello O; Palasciano G
    Clin Exp Med; 2015 Feb; 15(1):65-72. PubMed ID: 24323278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in Egyptian patients after liver transplantation.
    Mabrouk M; Esmat G; Yosry A; El-Serafy M; Doss W; Zayed N; El-Sahhar M; Awny S; Omar A
    Ann Hepatol; 2012; 11(6):882-90. PubMed ID: 23109452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
    Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pretransplantation liver status and health-related quality of life after grafting: a single-center prospective study.
    Kotarska K; Raszeja-Wyszomirska J; Wunsch E; Chmurowicz T; Kempińska-Podhorodecka A; Wójcicki M; Milkiewicz P
    Transplant Proc; 2014 Oct; 46(8):2770-3. PubMed ID: 25380914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation.
    Lai Q; Magistri P; Lionetti R; Avolio AW; Lenci I; Giannelli V; Pecchi A; Ferri F; Marrone G; Angelico M; Milana M; Schinniná V; Menozzi R; Di Martino M; Grieco A; Manzia TM; Tisone G; Agnes S; Rossi M; Di Benedetto F; Ettorre GM;
    Liver Int; 2021 Jul; 41(7):1629-1640. PubMed ID: 33793054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver transplant candidates have impaired quality of life across health domains as assessed by computerized testing.
    Stine JG; Stukenborg GJ; Wang J; Adkins A; Niccum B; Zimmet A; Argo CK
    Ann Hepatol; 2020; 19(1):62-68. PubMed ID: 31558420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation.
    Marrone G; Giannelli V; Agnes S; Avolio AW; Baiocchi L; Berardi G; Ettorre GM; Ferri F; Corradini SG; Grieco A; Guglielmo N; Lenci I; Lionetti R; Mennini G; Milana M; Rossi M; Spoletini G; Tisone G; Manzia TM; Lai Q
    Liver Int; 2024 Jan; 44(1):103-112. PubMed ID: 37752798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation?
    Rodrigue JR; Nelson DR; Reed AI; Hanto DW; Curry MP
    Prog Transplant; 2011 Sep; 21(3):207-14. PubMed ID: 21977881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study.
    Carbone M; Bufton S; Monaco A; Griffiths L; Jones DE; Neuberger JM
    J Hepatol; 2013 Sep; 59(3):490-4. PubMed ID: 23628322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada.
    Renfrew PD; Quan H; Doig CJ; Dixon E; Molinari M
    Can J Gastroenterol; 2011 Jul; 25(7):359-64. PubMed ID: 21876856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative resource utilization and survival among liver transplant recipients with Model for End-stage Liver Disease score ≥ 40: A retrospective cohort study.
    Cardoso FS; Karvellas CJ; Kneteman NM; Meeberg G; Fidalgo P; Bagshaw SM
    Can J Gastroenterol Hepatol; 2015 May; 29(4):185-91. PubMed ID: 25965438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposing a Sex-Adjusted Sodium-Adjusted MELD Score for Liver Transplant Allocation.
    Sealock JM; Ziogas IA; Zhao Z; Ye F; Alexopoulos SP; Matsuoka L; Chen G; Davis LK
    JAMA Surg; 2022 Jul; 157(7):618-626. PubMed ID: 35583884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Kardashian A; Ge J; McCulloch CE; Kappus MR; Dunn MA; Duarte-Rojo A; Volk ML; Rahimi RS; Verna EC; Ganger DR; Ladner D; Dodge JL; Boyarsky B; McAdams-DeMarco M; Segev DL; Lai JC
    Hepatology; 2021 Mar; 73(3):1132-1139. PubMed ID: 32491208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding.
    Biselli M; Gramenzi A; Lenzi B; Dall'Agata M; Pierro ML; Perricone G; Tonon M; Bellettato L; D'Amico G; Angeli P; Boffelli S; Bonavita ME; Domenicali M; Caraceni P; Bernardi M; Trevisani F
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1388-1397.e1. PubMed ID: 30557740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.